X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1316) 1316
Publication (119) 119
Book Chapter (18) 18
Book Review (17) 17
Conference Proceeding (8) 8
Book / eBook (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antidiuretic hormone receptor antagonists (736) 736
male (724) 724
humans (711) 711
animals (634) 634
index medicus (587) 587
vasopressin (505) 505
rats (454) 454
female (415) 415
hyponatremia (286) 286
benzazepines - therapeutic use (255) 255
middle aged (216) 216
pharmacology & pharmacy (212) 212
tolvaptan (208) 208
aged (194) 194
hyponatremia - drug therapy (184) 184
heart failure - drug therapy (182) 182
dose-response relationship, drug (168) 168
rats, sprague-dawley (168) 168
treatment outcome (158) 158
neurosciences (154) 154
receptors, vasopressin - metabolism (154) 154
arginine vasopressin - pharmacology (151) 151
benzazepines - administration & dosage (148) 148
rats, wistar (146) 146
antidiuretic-hormone (143) 143
blood pressure - drug effects (142) 142
sodium - blood (142) 142
heart failure (140) 140
adult (139) 139
benzazepines - pharmacology (138) 138
arginine-vasopressin (137) 137
antidiuretic hormone receptor antagonists - therapeutic use (135) 135
arginine vasopressin (125) 125
urology & nephrology (122) 122
endocrinology & metabolism (117) 117
medicine & public health (115) 115
hyponatremia - etiology (113) 113
cardiac & cardiovascular systems (111) 111
arginine vasopressin - analogs & derivatives (101) 101
physiology (101) 101
time factors (100) 100
osmolar concentration (98) 98
administration, oral (93) 93
receptors, vasopressin - physiology (93) 93
antidiuretic hormone (92) 92
analysis (90) 90
antidiuretic hormone receptor antagonists - administration & dosage (90) 90
pituitary hormones (90) 90
sodium (87) 87
care and treatment (86) 86
inappropriate secretion (86) 86
brain (85) 85
oxytocin (84) 84
heart failure - physiopathology (83) 83
aged, 80 and over (82) 82
double-blind (81) 81
antagonist (79) 79
antidiuretic hormone receptor antagonists - pharmacology (79) 79
benzazepines - adverse effects (79) 79
diuretics (79) 79
heart rate - drug effects (79) 79
double-blind method (76) 76
drug therapy (76) 76
mice (75) 75
mortality (75) 75
vasopressins - metabolism (71) 71
injections, intraventricular (69) 69
physiological aspects (69) 69
heart-failure (68) 68
research (68) 68
hyponatremia - physiopathology (67) 67
diuretics - therapeutic use (66) 66
medicine, general & internal (66) 66
arginine vasopressin - blood (65) 65
disease models, animal (63) 63
arginine vasopressin - metabolism (62) 62
internal medicine (61) 61
vasopressins - blood (61) 61
vasopressins - pharmacology (61) 61
vasopressins - physiology (60) 60
heart failure - complications (59) 59
hyponatremia - diagnosis (59) 59
kidney - drug effects (59) 59
retrospective studies (59) 59
arginine (58) 58
conivaptan (58) 58
health aspects (58) 58
indoles - pharmacology (58) 58
diuresis - drug effects (57) 57
hyponatremia - therapy (57) 57
nephrology (57) 57
blood pressure (56) 56
pyrrolidines - pharmacology (56) 56
receptor antagonist (56) 56
arginine vasopressin - physiology (55) 55
hyponatremia - blood (54) 54
receptor (54) 54
vasopressin receptor antagonist (54) 54
oral tolvaptan (53) 53
urine (53) 53
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1302) 1302
Japanese (9) 9
German (4) 4
Spanish (4) 4
French (3) 3
Russian (3) 3
Chinese (1) 1
Czech (1) 1
Hebrew (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 11/2017, Volume 73, Issue 11, pp. 1399 - 1408
Journal Article
British Journal of Pharmacology, ISSN 0007-1188, 07/2014, Volume 171, Issue 14, pp. 3511 - 3525
Background and Purpose Vasopressin V1B receptor antagonists may be effective for the treatment of depression and anxiety and the objective of this study was to... 
anxiety | arginine vasopressin | HPA axis | V1B receptor antagonist | depression | Anti-Anxiety Agents - administration & dosage | Antidiuretic Hormone Receptor Antagonists - pharmacology | Cricetulus | Rats, Wistar | Corticosterone | Pyridines - chemistry | Humans | Receptors, Vasopressin - metabolism | Male | Antidiuretic Hormone Receptor Antagonists - chemistry | Indoles - administration & dosage | Pyrimidinones - chemistry | Depression - drug therapy | Antidiuretic Hormone Receptor Antagonists - administration & dosage | Antidepressive Agents - chemistry | Depression - chemically induced | Proline - pharmacology | Anti-Anxiety Agents - chemistry | Indoles - pharmacology | Pyrimidinones - pharmacology | Antidepressive Agents - pharmacology | CHO Cells | Disease Models, Animal | Proline - administration & dosage | Pyridines - administration & dosage | Proline - analogs & derivatives | Administration, Oral | Anti-Anxiety Agents - pharmacology | Rats | Rats, Sprague-Dawley | Proline - chemistry | Animals | Antidepressive Agents - administration & dosage | Mice | Pyridines - pharmacology | Pyrimidinones - administration & dosage | Indoles - chemistry | Corticotropin releasing hormone | Arginine | Antidepressants | Analysis | Depression, Mental | ACTH | Social aspects | Vasopressin | Antianxiety agents | Pituitary gland | Hormones | Rodents | Research Papers
Journal Article
Journal Article